logo
Plus   Neg
Share
Email

Kohl's Affirms FY19 Adj. EPS Guidance - Quick Facts

While reporting financial results for the second quarter on Tuesday, retailer Kohl's Corp. (KSS) affirmed its adjusted earnings guidance for the full-year 2019. For the second quarter, the company reported that comparable sales decreased 2.9 percent.

For fiscal 2019, the company said it continues to expect adjusted earnings in the range of $5.15 to $5.45 per share.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $5.23 per share for the year. Analysts' estimates typically exclude special items.

Last week, Kohl's Board of Directors declared a quarterly cash dividend on the Company's common stock of $0.67 per share, payable on September 25, 2019 to shareholders of record at the close of business on September 11, 2019.

"We are confident that our upcoming brand launches, program expansions, and increased traffic from the Amazon returns program will incrementally contribute to our performance during the balance of the year and beyond," said Michelle Gass, Kohl's chief executive officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
NBCUniversal unveiled Peacock, a free premium ad-supported streaming service with subscription tiers offering more than 600 movies and 400 series. Peacock will be available on April 15 for Comcast's Xfinity X1 and Flex customers and on July 15 for the rest of the country. NBC is offering Peacock... The number of Amazon Prime members in the U.S. is growing slowly, but steadily, a recent study has shown. According to the survey by the Consumer Intelligence Research Partners, LLC or CIRP, the number of Amazon Prime members in the U.S. is estimated to have risen to 112 million in December 2019 from just over 100 million in the same period of the prior year. Medical device manufacturer Cardinal Health will soon recall certain Level 3 surgical gowns or PreSource procedural packs that contain these gowns following warning that they may not be sterile, the U.S. Food and Drug Administration said in a statement. The health regulator said it is working with the company to find out the specific product lots that are impacted.
Follow RTT
>